This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Millendo Therapeutics, Inc, University of Michigan. Active years: 2017-2024.
Company Filing History:
Years Active: 2017-2024
Title: Martin Douglas Phillips: Innovator in Pharmaceutical Development
Introduction
Martin Douglas Phillips is a notable inventor based in Bryn Mawr, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid drug forms. With a total of 3 patents, his work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Phillips' latest patents include a novel solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride, commonly referred to as ATR-101. This formulation is designed for oral dosing and is particularly useful in treating aberrant adrenocortical cellular activity, including conditions such as adrenocortical carcinoma (ACC), congenital adrenal hyperplasia (CAH), and Cushing's syndrome. His innovative approach to drug formulation aims to enhance the efficacy and accessibility of treatments for these serious health issues.
Career Highlights
Throughout his career, Martin Douglas Phillips has worked with prominent organizations, including Millendo Therapeutics, Inc. and the University of Michigan. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Some of his notable coworkers include Stephen Warren Hunt, III and Herman Chen. Their collaborative efforts have played a crucial role in advancing the research and development of innovative drug formulations.
Conclusion
Martin Douglas Phillips stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing effective treatments for complex medical conditions. His contributions through patents and collaborations highlight his commitment to innovation and improving patient care.